Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/19/2021 11/22/2021 11/23/2021 11/24/2021 11/26/2021 Date
128.81(c) 130.22(c) 130.48(c) 130.27(c) 125.62(c) Last
1 914 363 1 355 400 1 538 804 1 187 235 1 363 928 Volume
-0.06% +1.09% +0.20% -0.16% -3.57% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 7 877 M - -
Net income 2021 839 M - -
Net Debt 2021 6 446 M - -
P/E ratio 2021 32,1x
Yield 2021 0,76%
Sales 2022 8 141 M - -
Net income 2022 1 137 M - -
Net Debt 2022 4 890 M - -
P/E ratio 2022 23,5x
Yield 2022 0,78%
Capitalization 26 243 M 26 243 M -
EV / Sales 2021 4,15x
EV / Sales 2022 3,82x
Nbr of Employees 20 000
Free-Float 66,8%
More Financials
Company
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones,... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
12/02 | 01:00pmPresentation
More about the company
Ratings of Zimmer Biomet Holdings, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about ZIMMER BIOMET HOLDINGS, INC.
11/24ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
11/24NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
11/23Argus Downgrades Zimmer Biomet Holdings to Hold From Buy
MT
11/18ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial State..
AQ
11/18Zimmer Biomet to Present at Evercore ISI's 4th Annual HealthCONx Conference
PR
11/17Zimmer Biomet to Seek Acquisitions
CI
11/16Zimmer Biomet Keeps Quarterly Cash Dividend at $0.24 a Share, Payable Jan. 31 to Shareh..
MT
11/16Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2021
PR
11/16Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2021, Payable on or Ab..
CI
11/15ZIMMER BIOMET : Announces Cash Tender Offers for Certain Outstanding Debt Securities - For..
PU
11/15ZIMMER BIOMET HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/15Zimmer Biomet Announces Cash Tender Offers for Certain Outstanding Debt Securities
PR
11/15Zimmer Biomet Announces Cash Tender Offers for Certain Outstanding Debt Securities
CI
11/05Piper Sandler Adjusts Zimmer Biomet Holdings PT to $185 From $195, Maintains Overweight..
MT
11/05Barclays Adjusts Zimmer Biomet Holdings PT to $178 From $186, Maintains Overweight Rati..
MT
More news
News in other languages on ZIMMER BIOMET HOLDINGS, INC.
11/16Zimmer Biomet annonce un dividende trimestriel pour le quatrième trimestre de 2021, pay..
11/04Le bénéfice ajusté de Zimmer Biomet est stable au troisième trimestre ; le chiffre d'af..
11/04Zimmer Biomet révise ses prévisions pour l'exercice 21 après une chute au troisième tri..
11/04Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS affiche un chiffre d'affaires de 1,92 milli..
11/04GUIDANCE : (ZBH) ZIMMER BIOMET HOLDINGS prévoit une fourchette de bénéfices par action pou..
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 125,62 $
Average target price 169,29 $
Spread / Average Target 34,8%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-18.48%26 243
ABBOTT LABORATORIES14.97%222 592
MEDTRONIC PLC-5.20%149 347
BECTON, DICKINSON AND COMPANY-2.05%69 611
HOYA CORPORATION27.96%59 428
DEXCOM, INC.60.11%57 374